(Q38105995)

28 August 2017

title

Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy (English)

1 reference

28 August 2017

Johanna K DiStefano

1

1 reference

28 August 2017

Matthew Taila

series ordinal

2

1 reference

28 August 2017

M Lucrecia Alvarez

series ordinal

3

1 reference

28 August 2017

publication date

1 August 2013

1 reference

28 August 2017

published in

Current diabetes report

1 reference

28 August 2017

volume

13

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

582-591

1 reference

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Diabetic nephropathy in 2010: Alleviating the burden of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Kidney disease, genotype and the pathogenesis of vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

A genome-wide association study for diabetic nephropathy genes in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

New susceptibility loci associated with kidney disease in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Gene silencing by microRNAs: contributions of translational repression and mRNA decay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

MicroRNAs and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Role of microRNAs in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

MicroRNAs and the glomerulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

p38 MAP-kinases pathway regulation, function and role in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Activation and signaling of the p38 MAP kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

MicroRNA-195 promotes apoptosis in mouse podocytes via enhanced caspase activity driven by BCL2 insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Abated microRNA-195 expression protected mesangial cells from apoptosis in early diabetic renal injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Identification of a microRNA signature in renal fibrosis: role of miR-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Functional genetic variation of human miRNAs and phenotypic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

SNPs in human miRNA genes affect biogenesis and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Human polymorphism at microRNAs and microRNA target sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Allele-specific targeting of microRNAs to HLA-G and risk of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

The role of microRNA genes in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Sequence variants in SLITRK1 are associated with Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3'UTRs of human genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

dbSMR: a novel resource of genome-wide SNPs affecting microRNA mediated regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Evolution of treatment for diabetic nephropathy: historical progression from RAAS inhibition and onward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Expression of microRNAs in the urinary sediment of patients with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Urinary microRNA profiling in the nephropathy of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Serum microRNAs are promising novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Large-scale proteomics and phosphoproteomics of urinary exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Discovery of urinary biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Exosome isolation for proteomic analyses and RNA profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Towards microRNA-based therapeutics for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Inhibition of microRNA function by antimiR oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Inhibition of microRNA with antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

21 January 2018

MicroRNA therapeutics.

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0386-8

miR-21: a central regulator of fibrosis not only in the broken heart

21 January 2018

1 reference

12 December 2020

Familial factors determine the development of diabetic nephropathy in patients with IDDM.

1 reference

12 December 2020

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

1 reference

12 December 2020

Urinary miR-21, miR-29, and miR-93: novel biomarkers of fibrosis

1 reference

12 December 2020

The podocyte in diabetic kidney disease.

1 reference

12 December 2020

Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes

1 reference

12 December 2020

Isolation and purification of exosomes in urine

1 reference

12 December 2020

Microfiltration isolation of human urinary exosomes for characterization by MS

1 reference

12 December 2020

Urinary sediment miRNA levels in adult nephrotic syndrome

1 reference

12 December 2020

MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways

1 reference

12 December 2020

Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus

1 reference

12 December 2020

A Genome-Wide DNA Microsatellite Association Screen to Identify Chromosomal Regions Harboring Candidate Genes in Diabetic Nephropathy

1 reference

12 December 2020

Molecular mechanisms of diabetic mesangial cell hypertrophy: a proliferation of novel factors.

1 reference

12 December 2020

Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S11892-013-0386-8

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1007665063

0 references

1 reference